S&P 500

5.346,99

-0,11%

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Phoenix Biotech Aquisition Corporation (PBAX)
Phoenix Biotech Aquisition Corporation (PBAX) Notícias

PBAX

Phoenix Biotech Aquisition (PBAX)

Phoenix Biotech Aquisition Corporation

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:PBAX

1

Data	Hora	Fonte	Título	Código	Companhia
14/02/2024	18:48	Business Wire	Phoenix Biotech Acquisition Corp. and CERo Therapeutics, Inc. Announce Close of Business Combination	NASDAQ:PBAX	Phoenix Biotech Aquisition Corporation
07/06/2023	07:05	Edgar (US Regulatory)	Securities Registration: Business Combination (s-4)	NASDAQ:PBAX	Phoenix Biotech Aquisition Corporation
05/06/2023	10:27	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:PBAX	Phoenix Biotech Aquisition Corporation
05/06/2023	09:00	Business Wire	CERo Therapeutics, Inc. and Phoenix Biotech Acquisition Corp. Announce Merger Agreement to Create Public Company Advancing the Development of Next Generation Engineered T Cell Therapeutics	NASDAQ:PBAX	Phoenix Biotech Aquisition Corporation
12/05/2023	17:04	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:PBAX	Phoenix Biotech Aquisition Corporation
24/03/2023	07:02	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:PBAX	Phoenix Biotech Aquisition Corporation
14/02/2023	17:46	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:PBAX	Phoenix Biotech Aquisition Corporation
14/02/2023	08:11	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:PBAX	Phoenix Biotech Aquisition Corporation
20/12/2022	18:02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PBAX	Phoenix Biotech Aquisition Corporation
21/11/2022	10:39	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:PBAX	Phoenix Biotech Aquisition Corporation
04/11/2022	17:07	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:PBAX	Phoenix Biotech Aquisition Corporation
22/11/2021	18:15	GlobeNewswire Inc.	Phoenix Biotech Acquisition Corp. Class A Common Shares and Warrants to Commence Trading Separately on November 26, 2021	NASDAQ:PBAX	Phoenix Biotech Aquisition Corporation
08/10/2021	17:00	GlobeNewswire Inc.	Phoenix Biotech Acquisition Corp. Announces Completion of $175,000,000 Initial Public Offering, Including Exercise of Over-Allotment Option	NASDAQ:PBAX	Phoenix Biotech Aquisition Corporation
05/10/2021	18:19	GlobeNewswire Inc.	Phoenix Biotech Acquisition Corp. Announces Pricing of $155,000,000 Initial Public Offering	NASDAQ:PBAX	Phoenix Biotech Aquisition Corporation